comparemela.com

Latest Breaking News On - Novo holding - Page 7 : comparemela.com

As Catalent prepares to join Novo family, CDMO s sales continue to slide

As Catalent prepares to join Novo family, CDMO s sales continue to slide
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Catalent, Inc Reports Second Quarter Fiscal 2024 Results

Q2 24 net revenue of $1.03 billion decreased 10% as reported, or 11% in constant currency, compared to Q2 23. Q2 24 net revenue, excluding COVID-related revenue of ~$260 million in Q2’23 and.

Catalent Q2 sales inch past estimates amid takeover by Novo Holdings

The New Jersey-based firm is the main supplier of fill-finish work - involving filling and packaging syringes and injection pens in sterile conditions - for Novo's popular weight-loss drug, Wegovy. Catalent's shares were marginally higher at $56.70, compared with Novo's offer of $63.50 per share. "We've been surprised by the continued weakness," said Stephens analyst Jacob Johnson.

Catalent, Inc Reports Second Quarter Fiscal 2024 Results

Catalent, Inc Reports Second Quarter Fiscal 2024 Results
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Novo Holdings invests in Manipal Hospitals, largest deal in Asia

Novo Holdings invests in Manipal Hospitals, largest deal in Asia
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.